Abstract
Circulating RNA in plasma and serum is a newly developed area for molecular diagnosis. To date, increasing numbers of studies show that plasma and serum RNA could serve as both tumor- and fetal-specific markers for cancer detection and prenatal diagnosis, respectively. Recently, by introducing the highly sensitive one-step real-time quantitative reverse-transcription (RT)-polymerase chain reaction (PCR), these potentially valuable RNA species, which often only exist at low concentrations in plasma and serum, can now be readily detected and quantified. Following the successful quantification of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA in plasma of normal individuals, several placenta-derived mRNA species, including the mRNA transcripts of human placental lactogen (hPL), the β-subunit of human chorionic gonadotropin (βhCG), and corticotropin-releasing hormone (CRH) were also quantified in plasma of pregnant women. These circulating placental RNA species have provided the fetal-polymorphism-independent markers for prenatal diagnosis. The achievement in detecting the placental RNA in maternal plasma represents a significant step toward the development of RNA markers for noninvasive prenatal gene expression profiling. This detection technique can be extended to access a wide range of disease conditions, such as cancer and trauma. The one-step, realtime quantitative RT-PCR is a highly sensitive and specific, yet practically simple, RNA detection technique. This powerful technology may allow the practical employment of circulating RNA in the high-throughput clinical screening and monitoring applications.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lo, K. W., Lo, Y. M. D., Leung, S. F., et al. (1999) Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma. Clin. Chem. 45, 1292–1294.
Kopreski, M. S., Benko, F. A., Kwak, L. W., and Gocke, C. D. (1999) Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin. Cancer Res. 5, 1961–1965.
Chen, X. Q., Bonnefoi, H., Pelte, M. F., et al. (2000) Telomerase RNA as a detection marker in the serum of breast cancer patients. Clin. Cancer Res. 6, 3823–3826.
Wong, S. C. C., Lo, E. S. F., Cheung, M. T., et al. (2004) Quantification of plasma beta-catenin mRNA in colorectal cancer and adenoma patients. Clin. Cancer Res. 10, 1613–1617.
Gal, S., Fidler, C., Lo, Y. M. D., et al. (2001) Detection of mammaglobin mRNA in the plasma of breast cancer patients. Ann. N. Y. Acad. Sci. 945, 192–194.
Novakovic, S., Hocevar, M., Zgajnar, J., Besic, N., and Stegel, V. (2004) Detection of telomerase RNA in the plasma of patients with breast cancer, malignant melanoma or thyroid cancer. Oncol. Rep. 11, 245–252.
Fleischhacker, M., Beinert, T., Ermitsch, M., et al. (2001) Detection of amplifiable messenger RNA in the serum of patients with lung cancer. Ann. N. Y. Acad. Sci. 945, 179–188.
Silva, J. M., Rodriguez, R., Garcia, J. M., et al. (2002) Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells. Gut 50, 530–534.
Poon, L. L. M., Leung, T. N., Lau, T. K., and Lo, Y. M.D. (2000) Presence of fetal RNA in maternal plasma. Clin. Chem. 46, 1832–1834.
Reddi, K. K. and Holland, J. F. (1976) Elevated serum ribonuclease in patients with pancreatic cancer. Proc. Natl. Acad. Sci. USA 73, 2308–2310.
Ng, E. K. O., Tsui, N. B. Y., Lam, N. Y., et al. (2002) Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. Clin. Chem. 48, 1212–1217.
Tsui, N. B. Y., Ng, E. K. O., and Lo, Y. M. D. (2002) Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin. Chem. 48, 1647–1653.
Gibson, U. E., Heid, C. A., and Williams, P. M. (1996) A novel method for real time quantitative RT-PCR. Genome Res. 6, 995–1001.
Huggett, J. Dheda, K., Bustin, S., and Zumia, A. (2005) Real-time RT-PCR normalisation; strategies and considerations. Genes Immun. 6, 279–284.
Bustin, S. A. and Nolan, T. (2004) Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction. J. Biomol. Tech. 15, 155–166.
Dasi, F., Lledo, S., Garcia-Granero, E., et al. (2001) Real-time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA: a simple blood test to monitor disease in cancer patients. Lab. Invest. 81, 767–769.
Ng, E. K. O., Tsui, N. B. Y., Lau, T. K., et al. (2003) mRNA of placental origin is readily detectable in maternal plasma. Proc. Natl. Acad. Sci. USA 100, 4748–4753.
Bustin, S. A. (2000) Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J. Mol. Endocrinol. 25, 169–193.
Myers, T. W. and Gelfand, D. H. (1991) Reverse transcription and DNA amplification by a Thermus thermophilus DNA polymerase. Biochemistry 30, 7661–7666.
Chiu, R. W. K., Poon, L. L. M., Lau, T. K., Leung, T. N., Wong, E. M. C., and Lo, Y. M. D. (2001) Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma. Clin. Chem. 47, 1607–1613.
Chan, K.C. A., Yeung, S. W., Lui, W. B., Rainer, T. H., and Lo, Y. M. D. (2005) Effects of preanalytical factors on the molecular size of cell-free DNA in blood. Clin. Chem. 51, 781–784.
Wong, S. C. C., Lo, E. S. F., and Cheung, M. T. (2004) An optimised protocol for the extraction of non-viral mRNA from human plasma frozen for three years. J. Clin. Pathol. 57, 766–768.
Poddar, S. K., Sawyer, M. H., and Connor, J. D. (1998) Effect of inhibitors in clinical specimens on Taq and Tth DNA polymerase-based PCR amplification of influenza A virus. J. Med. Microbiol. 47, 1131–1135.
Acknowledgments
This work was supported by a Earmarked Research Grant (CUHK 4474/ 03M) from the Research Grants Council of the Hong Kong Special Administrative Region (China).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc.
About this protocol
Cite this protocol
Tsui, N.B.Y., Ng, E.K.O., Lo, Y.M.D. (2006). Molecular Analysis of Circulating RNA in Plasma. In: Lo, Y.M.D., Chiu, R.W.K., Chan, K.C.A. (eds) Clinical Applications of PCR. Methods in Molecular Biology™, vol 336. Humana Press. https://doi.org/10.1385/1-59745-074-X:123
Download citation
DOI: https://doi.org/10.1385/1-59745-074-X:123
Publisher Name: Humana Press
Print ISBN: 978-1-58829-348-0
Online ISBN: 978-1-59745-074-4
eBook Packages: Springer Protocols